174
Views
1
CrossRef citations to date
0
Altmetric
Letters to Editor

Start and End with Genetics: RCBTB1 and Beyond

, &
Pages 1932-1933 | Received 12 May 2021, Accepted 13 May 2021, Published online: 09 Jun 2021
 

ABSTRACT

Heterozygous truncation variants in RCBTB1 have been reported to cause familial exudative vitreoretinopathy (FEVR). Such genotype-phenotype association is not supported by our recent study based on big data from our own, HGMD, and gnomAD. The authors, who reported association between RCBTB1 and FEVR, made further explanation on their own results without additional supporting data. In response to their comments, we would like to further clarify the pathogenesis of heterozygous truncation variants in RCBTB1 based on the current understanding of variant curation at individual gene level. Genes associated with FEVR are of great attention since it has been recognized as a common disease-causing blindness in children and adolescents. Curation of questionable causative genes or variant curation in well-known genes is a critical task in clinical gene test at the era of next-generation sequencing, since clinical application of biomarkers in questions may lead to inappropriate management or even disastrous consequence.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China [81970837]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.